semaglutide and bone loss GLP-1s Health: What the Evidence Says About Semaglutide, Bone Density, and Muscle Frontiers | Bone mineral density

Back Lasker Foundation (2024) 'GLP-1-based therapy for obesity'

Serious Side Effects and When to Contact a Provider Serious side effects are uncommon, but medical guidance is important if you experience: Severe or persistent abdominal pain Ongoing vomiting Signs of dehydration such as confusion or minimal urination Symptoms of low blood sugar, including shakiness, sweating, or rapid heartbeat Prompt communication with your provider helps prevent complications

Faster dose escalation can intensify appetite suppression but increases nausea and side-effect risk without improving the fundamental timeline of weight loss

Matsuo T

Differences between males and females in determining exercise intensity